Securities and Exchange Commission v. Rayat et al
Case Number:
1:21-cv-04777
Court:
Nature of Suit:
Judge:
Firms
Government Agencies
-
February 28, 2024
Biotech Co., Ex-Exec And Investor To Pay $5.2M In SEC Suit
A New York federal judge entered final judgments against medical device company RenovaCare, its controlling shareholder, and its former chief operating officer to settle a U.S. Securities and Exchange Commission suit accusing them of artificially inflating RenovaCare's stock price, ordering them to pay a total of $5.2 million.
-
October 18, 2023
Biotech Co. Shareholders To Pay $3M To End SEC Fraud Suit
An ex-executive of RenovaCare and a shareholder have agreed to pay about $3 million to settle a U.S. Securities and Exchange Commission suit accusing them of artificially inflating the stock price of the biotech company.